Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer
Our study indicated that combination of PO and anti-PD-1 could synergistically suppress CRC progression and altered the tumor microenvironment in favor of antitumor immune responses.
Authors
- Jiawen Li (ORCID: https://orcid.org/0000-0003-3684-4785)
- Tianpeng Du
- Xiaodong Jiang (ORCID: https://orcid.org/0000-0002-9656-4972)
- Yuanyuan Wang (ORCID: https://orcid.org/0000-0001-9472-8606)
- Chenxi Hu (ORCID: https://orcid.org/0000-0002-8397-9319)
- Kaiyuan Hui
Institutions
- Xuzhou Medical College (CN)
- Lianyungang Oriental Hospital (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.3389/fonc.2025.1528004
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05